Evaluation of the safety and efficacy of a novel product for the removal of impacted human cerumen.

Douglas FullingtonJenny SongAntionette GillesXiaowen GuoWaley HuaC Eric AndersonJoseph Griffin

Published in: BMC ear, nose, and throat disorders (2017)

This trial is registered on http://www.clinicaltrials.gov/. The registration number is NCT02829294. The trial was retrospectively registered on July 8, 2016.

Keyphrases

phase iii
study protocol
phase ii
clinical trial
endothelial cells
randomized controlled trial
open label
induced pluripotent stem cells